Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.
Villaverde-González R, Gracia Gil J, Pérez Sempere A, Millán Pascual J, Marín Marín J, Carcelén Gadea M, Gabaldón Torres L, Moreno Escribano A, Candeliere Merlicco A.
Villaverde-González R, et al. Among authors: marin marin j.
Eur Neurol. 2017;77(3-4):130-136. doi: 10.1159/000453333. Epub 2017 Jan 5.
Eur Neurol. 2017.
PMID: 28052269